5:53 PM
 | 
Jun 04, 2008
 |  BC Extra  |  Clinical News

Transcept's Intermezzo meets insomnia endpoint

Transcept (Point Richmond, Calif.) said Intermezzo significantly reduced time to sleep onset, the primary endpoint, by 18 minutes vs. placebo in a...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >